Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
D. A. Laplaud
,
L. Barbin
,
Chloé Rousseau
,
N. Jousset
,
Romain Casey
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63
Journal articles
hal-01259392v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Disease-modifying therapies use in primary progressive multiple sclerosis patients in France data from the OFSEP cohort over the 1996-2017 period
Emmanuelle Leray
,
F. Rollot
,
Romain Casey
,
J. de Seze
,
D. A. Laplaud
et al.
Journal articles
hal-01716028v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Exploring T cell - B cell collaboration in multiple sclerosis through B cell differentiation analysis
J. Morille
,
S. Rodriguez
,
P. Ame Thomas
,
K. Tarte
,
A. Garcia
et al.
Multiple Sclerosis Journal , 2019, 25, pp.662-663
Journal articles
hal-02355532v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Disease-modifying therapies use in relapsing-onset multiple sclerosis patients in real-life settings in France data from the OFSEP database over the period 1996-2017
Emmanuelle Leray
,
F. Rollot
,
Romain Casey
,
J. de Seze
,
D. A. Laplaud
et al.
Journal articles
hal-01716027v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
B cell differentiation is defective in multiple sclerosis patients
J. Morille
,
F. Lejeune
,
M. Chesneau
,
A. Garcia
,
L. Berthelot
et al.
Multiple Sclerosis Journal , 2018, 24, pp.392-392
Journal articles
hal-01974927v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The OFSEP high definition cohort to prognosticate the evolution of multiple sclerosis at clinical key steps of the disease
Romain Casey
,
Francis Guillemin
,
D. A. Laplaud
,
Emmanuelle Leray
,
J. Epstein
et al.
Journal articles
hal-01939727v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More